1352306-68-3

Basic information

• Product Name: p-chlorophenyl 4,6-O-benzylidene-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-1-thio-β-D-galactopyranoside
• Synonyms: p-chlorophenyl 4,6-O-benzylidene-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-1-thio-β-D-galactopyranoside
• CAS NO: 1352306-68-3
• Molecular Weight: 569.29
• Mol File: 1352306-68-3.mol

Chemical Properties

• CAS DataBase Reference: p-chlorophenyl 4,6-O-benzylidene-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-1-thio-β-D-galactopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: p-chlorophenyl 4,6-O-benzylidene-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-1-thio-β-D-galactopyranoside(1352306-68-3)
• EPA Substance Registry System: p-chlorophenyl 4,6-O-benzylidene-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-1-thio-β-D-galactopyranoside(1352306-68-3)

Safety Data

• Hazardous Substances Data: 1352306-68-3(Hazardous Substances Data)

Upstream product

• 1258839-49-4 p-chlorophenyl 2-acetamido-3-O-acetyl-2-deoxy-4,6-di-O-pivaloyl-1-thio-β-D-galactopyranoside 
• 1352306-62-7 p-chlorophenyl 2-amino-2-deoxy-1-thio-β-D-galactopyranoside 
• 1125-88-8 benzaldehyde dimethyl acetal 
• 1352306-66-1 p-chlorophenyl 2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-1-thio-β-D-galactopyranoside 

Downstream Products

• 1352307-19-7 p-chlorophenyl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-α-D-galactopyranosyl-(1->3)-4,6-O-benzylidene-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-1-thio-β-D-galactopyranoside 
• 1352307-22-2 p-chlorophenyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl-(1->3)-4,6-O-benzylidene-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-1-thio-β-D-galactopyranoside 
• 1352306-70-7 p-chlorophenyl 3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-1-thio-β-D-galactopyranoside 

Relevant articles and documents

Synthesis of a Forssman antigen derivative for use in a conjugate vaccine

The total chemical synthesis of a Forssman antigen analog is described. The pentasaccharide contains a functionalized tether which should facilitate future conjugation with immunogenic proteins. We found that the total synthesis can be efficiently achieved by following a convergent 2+3 strategy, and using N-Troc protected GalNAc thioglycoside as a donor.